Compare NSA & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSA | BHC |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2015 | N/A |
| Metric | NSA | BHC |
|---|---|---|
| Price | $32.68 | $5.88 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $32.63 | $8.67 |
| AVG Volume (30 Days) | 1.6M | ★ 2.2M |
| Earning Date | 02-25-2026 | 02-18-2026 |
| Dividend Yield | ★ 7.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.61 | ★ 0.97 |
| Revenue | $741,511,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | N/A | $6.81 |
| Revenue Next Year | $0.65 | $4.11 |
| P/E Ratio | $52.85 | ★ $5.92 |
| Revenue Growth | N/A | ★ 5.86 |
| 52 Week Low | $27.43 | $4.25 |
| 52 Week High | $40.62 | $8.69 |
| Indicator | NSA | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | 34.44 |
| Support Level | $31.82 | $5.62 |
| Resistance Level | $33.28 | $5.85 |
| Average True Range (ATR) | 0.79 | 0.20 |
| MACD | -0.10 | -0.05 |
| Stochastic Oscillator | 52.62 | 19.35 |
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.